This suggests that detachment cultured non-stem cancer cells resistant to anoikis could be a source of induced CSCs with metastatic potential or MICs, and also indicates that targeting CD147 could be a promising therapeutic strategy for lethal metastatic breast cancer by eliminating induced CSCs. This evidence concerns the gene BSG and cancer.